Gottlieb Pushes Subscription Reimbursement In Plan To Curb Antibiotic Resistance

By David Roza / September 14, 2018 at 7:26 PM
FDA Commissioner Scott Gottlieb said his agency is discussing with public and private payers the possibility of establishing a subscription-based reimbursement policy that offers an incentive for drug makers to develop new antibiotics while health care providers are pressed to cut down on use of those drugs. Gottlieb said FDA alone will not be able to fix the systemic problems behind the growth of antimicrobial resistance (AMR). He announced an extensive plan Friday (Sept. 14) that calls for: facilitating new...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.